PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1490003
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1490003
The global medical electrodes market is estimated to be valued at USD 1,147.9 Mn in 2024 and is expected to reach USD 1,538.4 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 1,147.9 Mn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 4.30% | 2031 Value Projection: | US$ 1,538.4 Mn |
The global medical electrodes market has been witnessing steady growth over the years owing to the rising incidence of chronic disorders and increasing preference for home healthcare and ambulatory care services. Various technological advancements in medical devices have led to the development of advanced electrode types such as dry, needle, and solid gel electrodes that offer higher conductivity and precision. Moreover, growing investments by prominent players to develop patient-friendly electrodes are expanding the potential scope of the market. However, the high costs associated with medical electrodes limit their widespread adoption in developing countries. Nonetheless, the growing geriatric population susceptible to cardiovascular and neurological disorders will continue stimulating the demand for electrodes in the coming years.
The global medical electrodes market is driven by the rising prevalence of target diseases, increasing investments in clinical research, and technical advancements in electrodes. However, high costs associated with medical devices act as a restraint. Emergence of home healthcare offers lucrative growth opportunities. The rising incidence of cardiovascular diseases, neurological disorders, and respiratory diseases across the globe has fueled the demand for medical equipment including electrodes for diagnosis and treatment. As per the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death worldwide. This has prompted manufacturers to invest heavily in R&D to develop affordable and innovative electrode technologies. On the other hand, technical complexities and required expertise for production raise manufacturing costs. This hinders wider adoption, especially in developing nations with lower healthcare budgets. Nevertheless, the growing preference for non-institutional care is poised to present attractive opportunities. Home healthcare offers comfort to patients and reduces cost burdens on governments and private insurers. This is expected to augment the demand for easy-to-use electrodes for self-monitoring and home-based therapies.
Detailed Segmentation-